{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:17:42Z","timestamp":1792793862819,"version":"4.5.0"},"reference-count":24,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,5,24]],"date-time":"2004-05-24T00:00:00Z","timestamp":1085356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Helicobacter"],"published-print":{"date-parts":[[2004,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Background and Aim.\u2002<\/jats:bold>  <jats:italic>Helicobacter pylori<\/jats:italic> is the major cause of peptic ulcer disease, but the proportion of <jats:italic>H.\u00a0pylori<\/jats:italic>\u2010negative peptic ulcers seems to be increasing in developed countries. We investigated the frequency of <jats:italic>H.\u00a0pylori\u2010<\/jats:italic>negative peptic ulcer without intake of nonsteroidal anti\u2010inflammatory drugs (NSAIDs) in a Mediterranean European country.<\/jats:p><jats:p><jats:bold>Materials and Methods.\u2002<\/jats:bold> We prospectively collected consecutive patients with an endoscopically verified active peptic ulcer over 6\u00a0months from different areas of Spain. <jats:italic>Helicobacter pylori<\/jats:italic> infection was assessed by rapid urease test and histologic examination (corpus and antral biopsies). A <jats:sup>13<\/jats:sup>C\u2010urea breath test was performed if <jats:italic>H.\u00a0pylori<\/jats:italic> was not detected with the invasive test. Patients were considered <jats:italic>H.\u00a0pylori<\/jats:italic>\u2010negative if all three tests were negative. NSAID use was determined by structured data collection.<\/jats:p><jats:p><jats:bold>Results.\u2002<\/jats:bold> Of 754 consecutive peptic ulcer patients, 16 (2.1%) were <jats:italic>H.\u00a0pylori<\/jats:italic>\u2010negative and had not used NSAIDs before the diagnosis. Of the 472 patients who had duodenal ulcers, 95.7% (n\u00a0=\u00a0452) were <jats:italic>H.\u00a0pylori<\/jats:italic>\u2010positive and only 1.69% (n\u00a0=\u00a08) were negative for both <jats:italic>H.\u00a0pylori<\/jats:italic> infection and NSAID use; 193 patients had benign gastric ulcers and 87% (n\u00a0=\u00a0168) of them were infected by <jats:italic>H.\u00a0pylori<\/jats:italic> (<jats:italic>p<\/jats:italic>\u00a0&lt;\u00a0.001 vs. duodenal ulcers). NSAID intake was more frequent in gastric ulcer patients (52.8%) than in duodenal ulcer patients (25.4%; <jats:italic>p<\/jats:italic>\u00a0&lt;\u00a0.001). Consequently, the frequency of <jats:italic>H.\u00a0pylori<\/jats:italic>\u2010negative gastric ulcer in patients not using NSAID was 4.1% (n\u00a0=\u00a08).<\/jats:p><jats:p><jats:bold>Conclusion.\u2002<\/jats:bold> Peptic ulcer disease is still highly associated with <jats:italic>H.\u00a0pylori<\/jats:italic> infection in southern Europe, and only 1.6% of all duodenal ulcers and 4.1% of all gastric ulcers were not associated with either <jats:italic>H.\u00a0pylori<\/jats:italic> infection or NSAID use.<\/jats:p>","DOI":"10.1111\/j.1083-4389.2004.00219.x","type":"journal-article","created":{"date-parts":[[2004,5,24]],"date-time":"2004-05-24T15:32:47Z","timestamp":1085412767000},"page":"249-254","source":"Crossref","is-referenced-by-count":63,"title":["The Prevalence of Peptic Ulcer not Related to <i>Helicobacter pylori<\/i> or Non\u2010Steroidal Anti\u2010Inflammatory Drug Use is Negligible in Southern Europe"],"prefix":"10.1111","volume":"9","author":[{"given":"Ma Teresa","family":"Arroyo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montse","family":"Forne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Martin","family":"De Argila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faust","family":"Feu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Arenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"De La Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Garrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Bujanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Cosme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Castiella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier P.","family":"Gisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Hervas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Lanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,5,24]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Curved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"16","author":"Marshall BJ","year":"1984","journal-title":"Lancet"},{"key":"e_1_2_5_3_2","first-page":"8","article-title":"Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report","volume":"41","author":"European Helicobacter Pylori Study Group","year":"1997","journal-title":"European Helicobacter Pylori Study Group"},{"key":"e_1_2_5_4_2","first-page":"289","article-title":"Epidemiology of peptic ulcer disease","volume":"13","author":"Kurata JH","year":"1984","journal-title":"Gastroenterology"},{"key":"e_1_2_5_5_2","first-page":"937","article-title":"Helicobacter pylori and nonsteroidal anti\u2010inflammatory drugs","volume":"30","author":"Chan FK","year":"2001","journal-title":"Clin North Am"},{"key":"e_1_2_5_6_2","first-page":"59","article-title":"The prevalence of Helicobacter pylori in peptic ulcer disease","volume":"9","author":"Kuipers EJ","year":"1995","journal-title":"Pharmacol Ther"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11030-0"},{"key":"e_1_2_5_8_2","first-page":"2950","article-title":"Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs","volume":"97","author":"Quan C","year":"2002","journal-title":"J Gastroenterol"},{"key":"e_1_2_5_9_2","first-page":"1403","article-title":"Helicobacter pylori\u2010negative gastric ulcer","volume":"87","author":"Borody TJ","year":"1992","journal-title":"J Gastroenterol"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90067-8"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199801000-00016"},{"key":"e_1_2_5_12_2","first-page":"574","article-title":"Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified?","volume":"93","author":"Jyotheeswaran S","year":"1998","journal-title":"J Gastroenterol"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200007000-00010"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03774.x"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.6.762"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026669123593"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01214.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1998.tb01961.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2000.tb139318.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200012060-00010"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005600831851"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)80069-3"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199612000-00006"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00631.x"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1067\/mge.2001.112840"}],"container-title":["Helicobacter"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1083-4389.2004.00219.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1083-4389.2004.00219.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T17:30:48Z","timestamp":1697131848000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1083-4389.2004.00219.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,24]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["10.1111\/j.1083-4389.2004.00219.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1083-4389.2004.00219.x","archive":["Portico"],"relation":{},"ISSN":["1083-4389","1523-5378"],"issn-type":[{"value":"1083-4389","type":"print"},{"value":"1523-5378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,24]]}}}